Thyroglobulin gene mutations producing defective intracellular transport of thyroglobulin are associated with increased thyroidal type 2 iodothyronine deiodinase activity

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1451-1457

  Kanou, Yasuhiko ^a   Hishinuma, Akira ^b   Tsunekawa, Katsuhiko ^c   Seki, Koji ^c   Mizuno, Yutaka ^a,d   Fujisawa, Haruki ^a   Imai, Tsuneo ^d   Miura, Yoshitaka ^d,e   Nagasaka, Tetsuro ^d   Yamada, Chizumi ^d,f   Ieiri, Tamio ^b   Murakami, Masami ^c   Murata, Yoshiharu ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Graduate School of Medicine ^*  (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THIAMAZOLE; THYROGLOBULIN; THYROXINE; THYROXINE DEIODINASE;

ADULT; ARTICLE; CASE REPORT; CELL TRANSPORT; CHEMICAL ANALYSIS; ENZYME ACTIVITY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE MUTATION; GOITER; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT; THYROID GLAND;

EID: 34147192259     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1242     Document Type: Article

References (28)

1. van de Graaf SA, Cammenga M, Ponne NJ, Veenboer GJ, Gons MH, Orgiazzi J, de Vijlder JJ, Ris-Stalpers C 1999 The screening for mutations in the thyroglobulin cDNA from six patients with congenital hypothyroidism. Biochimie (Paris) 81:425-432
2. Medeiros-Neto G, Targovnik HM, Vassart G 1993 Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocr Rev 14:165-183
3. de Vijlder JJ 2003 Primary congenital hypothyroidism: defects in iodine pathways. Eur J Endocrinol 149:247-256
4. Vono-Toniolo J, Rivolta CM, Targovnik HM, Medeiros-Neto G, Kopp P 2005 Naturally occurring mutations in the thyroglobulin gene. Thyroid 15:1021-1033
5. van de Graaf SA, Ris-Stalpers C, Veenboer GJ, Cammenga M, Santos C, Targovnik HM, de Vijlder JJ, Medeiros-Neto G 1999 A premature stopcodon in thyroglobulin messenger RNA results in familial goiter and moderate hypothyroidism. J Clin Endocrinol Metab 84:2537-2542
6. Targovnik HM, Medeiros-Neto G, Varela V, Cochaux P, Wajchenberg BL, Vassart G 1993 A nonsense mutation causes human hereditary congenital goiter with preferential production of a 171-nucleotide-deleted thyroglobulin ribonucleic acid messenger. J Clin Endocrinol Metab 77:210-215
7. Ieiri T, Cochaux P, Targovnik HM, Suzuki M, Shimoda S, Perret J, Vassart G 1991 A 3′ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 88:1901-1905
8. Hishinuma A, Takamatsu J, Ohyama Y, Yokozawa T, Kanno Y, Kuma K, Yoshida S, Matsuura N, Ieiri T 1999 Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin cause a defect in intracellular transport of thyroglobulin in patients with congenital goiter and the variant type of adenomatous goiter. J Clin Endocrinol Metab 84:1438-1444
9. Hishinuma A, Fukata S, Nishiyama S, Nishi Y, Oh-Ishi M, Murata Y, Ohyama Y, Matsuura N, Kasai K, Harada S, Kitanaka S, Takamatsu J, Kiwaki K, Ohye H, Uruno T, Tomoda C, Tajima T, Kuma K, Miyauchi A, Ieiri T 2006 Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab 91:3100-3104
10. Hishinuma A, Fukata S, Kakudo K, Murata Y, Ieiri T 2005 High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid 15:1079-1084
11. Calvo R, Obregon MJ, Ruiz de Ona C, Escobar del Rey F, Morreale de Escobar G 1990 Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3′-triiodothyronine in the protection of the fetal brain. J Clin Invest 86:889-899
12. Bernal J 2002 Action of thyroid hormone in brain. J Endocrinol Invest 25:268-288
13. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533
14. Hishinuma A, Kasai K, Masawa N, Kanno Y, Arimura M, Shimoda SI, Ieiri T 1998 Missense mutation (C1263R) in the thyroglobulin gene causes congenital goiter with mild hypothyroidism by impaired intracellular transport. Endocr J 45:315-327
15. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular cloning, a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press
16. Murata Y, Magner JA, Refetoff S 1986 The role of glycosylation in the molecular conformation and secretion of thyroxine-binding globulin. Endocrinology 118:1614-1621
17. Murata Y, Sueda K, Seo H, Matsui N 1989 Studies on the role of glycosylation for human corticosteroid-binding globulin: comparison with that for thyroxine-binding globulin. Endocrinology 125:1424-1429
18. Murakami M, Araki O, Hosoi Y, Kamiya Y, Morimura T, Ogiwara T, Mizuma H, Mori M 2001 Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 142:2961-2967
19. Murakami M, Tanaka K, Greer MA 1988 There is a nyctohemeral rhythm of type II iodothyronine 5′-deiodinase activity in rat anterior pituitary. Endocrinology 123:1631-1635
20. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
21. Kim BW, Daniels GH, Harrison BJ, Price A, Harney JW, Larsen PR, Weetman AP 2003 Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab 88:594-598
22. Weetman AP, Shepherdley CA, Mansell P, Ubhi CS, Visser TJ 2003 Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. Eur J Endocrinol 149:443-447
23. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
24. Burmeister LA, Pachucki J, St Germain DL 1997 Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138:5231-5237
25. Gereben B, Goncalves C, Harney JW, Larsen PR, Bianco AC 2000 Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol Endocrinol 14:1697-1708
26. Botero D, Gereben B, Goncalves C, De Jesus LA, Harney JW, Bianco AC 2002 Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. Mol Endocrinol 16:1999-2007
27. Baryshev M, Sargsyan E, Wallin G, Lejnieks A, Furudate S, Hishinuma A, Mkrtchian S 2004 Unfolded protein response is involved in the pathology of human congenital hypothyroid goiter and rat non-goitrous congenital hypothyroidism. J Mol Endocrinol 32:903-920
28. Hampton RY 2002 ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 14:476-482